Neuromuscular blocking agents for patients with acute respiratory distress syndrome

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: We will assess the effectiveness and safety of using neuromuscular blocking agents within 48 hours of initiation of mechanical ventilation for ARDS patients.